---
title: "ARGX: Q2 revenue up 60% YoY, VYVGART expands in MG/CIDP, pipeline and financials remain strong"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293638677.md"
description: "Q2 2026 saw record revenue growth of 60% year-over-year, driven by VYVGART's strong performance in MG and CIDP, including the seronegative MG launch. Pipeline progress and label expansions are set to sustain long-term growth, with robust financials and disciplined capital allocation.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-23T15:04:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293638677.md)
  - [en](https://longbridge.com/en/news/293638677.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293638677.md)
---

# ARGX: Q2 revenue up 60% YoY, VYVGART expands in MG/CIDP, pipeline and financials remain strong

Q2 2026 saw record revenue growth of 60% year-over-year, driven by VYVGART's strong performance in MG and CIDP, including the seronegative MG launch. Pipeline progress and label expansions are set to sustain long-term growth, with robust financials and disciplined capital allocation.

Based on

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)

## Related News & Research

- [Orbimed Advisors LLC Lowers Holdings in argenex SE $ARGX](https://longbridge.com/en/news/293914032.md)
- [ARGX: $2.2B acquisition adds FB102, advancing autoimmune pipeline and Vision 2030 goals](https://longbridge.com/en/news/293927936.md)
- [ARGX: Q2 2026 delivered 60% sales growth and expanded VYVGART reach, with strong profit gains](https://longbridge.com/en/news/293564456.md)
- [Capgemini sees multi-year IT modernisation boom as firms prepare for AI](https://longbridge.com/en/news/294321168.md)
- [BB: H1 2026 delivered growth, margin gains, and a raised outlook, with caution for H2](https://longbridge.com/en/news/294324396.md)